Company intelligence / Profile preview

Corrona

Ahmedabad, Gujarat, India

Ownership: Private
Development stage: Other

Overview

Corona Remedies is a commercial-stage pharmaceutical company with over 80 brands, focusing on marketed prescription and consumer health products in India. The company recently acquired the muscle relaxant brand Myoril from Sanofi to strengthen its product portfolio[2].

Therapeutic areas: Women's HealthEndocrinologyCardiovascularNeurologyMetabolic Disorders
Modalities: Small moleculeProtein
Industry: Biotech

Partnerships

Sanofi (acquisition of Myoril muscle relaxant brand)[2]La Chandra Pharmalab (minority stake in hormone API manufacturing)[2]

Beyond the preview

Go deeper on Corrona.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corrona.

Explore the full profile